Mechanism of activation of the classical pathway of complement by monoclonal IgE (DES). Restricted regulation of C4b by C4b-binding protein
- PMID: 6608450
- DOI: 10.1002/eji.1830140310
Mechanism of activation of the classical pathway of complement by monoclonal IgE (DES). Restricted regulation of C4b by C4b-binding protein
Abstract
A human monoclonal IgE from patient DES, IgE (DES), has been shown to activate the classical pathway of complement. The mechanism of this activation has been investigated and can be summarized as follows: (a) IgE (DES) is able to bind and activate C1 in a dose-dependent fashion. This activation increases with the size of the aggregates used, but the affinity of C1 for IgE (DES) is weaker than for IgG. (b) A classical pathway C3 convertase can be assembled on IgE (DES) using purified C1, C4 and C2. The formation decay of this convertase is similar to that formed on IgG with an half-life of 9 min at 37 degrees C. (c) The extrinsic regulation of the C3 convertase by C4bp is restricted on IgE (DES) as compared to IgG. This restriction is shown on both the formation and the decay of the convertase. The mechanism of activation of the classical pathway of complement by IgE (DES) thus present some similarities with the assembly of the C3 convertase by the alternative pathway.
Similar articles
-
Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.J Immunol. 1983 Jul;131(1):403-8. J Immunol. 1983. PMID: 6602833
-
A model system for the study of the assembly and regulation of human complement C3 convertase (classical pathway).Eur J Immunol. 1986 Jun;16(6):617-22. doi: 10.1002/eji.1830160606. Eur J Immunol. 1986. PMID: 3487454
-
Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.Eur J Immunol. 1984 Dec;14(12):1111-4. doi: 10.1002/eji.1830141209. Eur J Immunol. 1984. PMID: 6240408
-
Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.Transplant Proc. 1977 Mar;9(1):729-39. Transplant Proc. 1977. PMID: 325806 Review.
-
Complement: activation, consequences, and control.Am J Med Technol. 1982 Sep;48(9):735-42. Am J Med Technol. 1982. PMID: 6215861 Review.
Cited by
-
Self-reactive IgE and anti-IgE therapy in autoimmune diseases.Front Pharmacol. 2023 Jan 23;14:1112917. doi: 10.3389/fphar.2023.1112917. eCollection 2023. Front Pharmacol. 2023. PMID: 36755957 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous